Cargando…
Evaluation of Immunogenicity of an Inactivated SARS-CoV-2 Vaccine Prototype in vitro
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Mosby, Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804389/ http://dx.doi.org/10.1016/j.jaci.2021.12.339 |
| _version_ | 1784643067356119040 |
|---|---|
| author | Hancharou, Andrei Antonevich, N. Pozniak, T. Babrukevich, Darya Semizhon, P. Scheslenok, E. Rynda, A. Timohina, O. Minich, Y. DuBuske, Lawrence |
| author_facet | Hancharou, Andrei Antonevich, N. Pozniak, T. Babrukevich, Darya Semizhon, P. Scheslenok, E. Rynda, A. Timohina, O. Minich, Y. DuBuske, Lawrence |
| author_sort | Hancharou, Andrei |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8804389 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Published by Mosby, Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88043892022-02-01 Evaluation of Immunogenicity of an Inactivated SARS-CoV-2 Vaccine Prototype in vitro Hancharou, Andrei Antonevich, N. Pozniak, T. Babrukevich, Darya Semizhon, P. Scheslenok, E. Rynda, A. Timohina, O. Minich, Y. DuBuske, Lawrence J Allergy Clin Immunol Article Published by Mosby, Inc. 2022-02 2022-02-01 /pmc/articles/PMC8804389/ http://dx.doi.org/10.1016/j.jaci.2021.12.339 Text en Copyright © 2021 Published by Mosby, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Hancharou, Andrei Antonevich, N. Pozniak, T. Babrukevich, Darya Semizhon, P. Scheslenok, E. Rynda, A. Timohina, O. Minich, Y. DuBuske, Lawrence Evaluation of Immunogenicity of an Inactivated SARS-CoV-2 Vaccine Prototype in vitro |
| title | Evaluation of Immunogenicity of an Inactivated SARS-CoV-2 Vaccine Prototype in vitro |
| title_full | Evaluation of Immunogenicity of an Inactivated SARS-CoV-2 Vaccine Prototype in vitro |
| title_fullStr | Evaluation of Immunogenicity of an Inactivated SARS-CoV-2 Vaccine Prototype in vitro |
| title_full_unstemmed | Evaluation of Immunogenicity of an Inactivated SARS-CoV-2 Vaccine Prototype in vitro |
| title_short | Evaluation of Immunogenicity of an Inactivated SARS-CoV-2 Vaccine Prototype in vitro |
| title_sort | evaluation of immunogenicity of an inactivated sars-cov-2 vaccine prototype in vitro |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804389/ http://dx.doi.org/10.1016/j.jaci.2021.12.339 |
| work_keys_str_mv | AT hancharouandrei evaluationofimmunogenicityofaninactivatedsarscov2vaccineprototypeinvitro AT antonevichn evaluationofimmunogenicityofaninactivatedsarscov2vaccineprototypeinvitro AT pozniakt evaluationofimmunogenicityofaninactivatedsarscov2vaccineprototypeinvitro AT babrukevichdarya evaluationofimmunogenicityofaninactivatedsarscov2vaccineprototypeinvitro AT semizhonp evaluationofimmunogenicityofaninactivatedsarscov2vaccineprototypeinvitro AT scheslenoke evaluationofimmunogenicityofaninactivatedsarscov2vaccineprototypeinvitro AT ryndaa evaluationofimmunogenicityofaninactivatedsarscov2vaccineprototypeinvitro AT timohinao evaluationofimmunogenicityofaninactivatedsarscov2vaccineprototypeinvitro AT minichy evaluationofimmunogenicityofaninactivatedsarscov2vaccineprototypeinvitro AT dubuskelawrence evaluationofimmunogenicityofaninactivatedsarscov2vaccineprototypeinvitro |